Teladoc Health, Inc. (TDOC) Financial Statements
Teladoc Health, Inc. (TDOC) reported trailing twelve-month revenue of $2.5B (down 2.1% year on year) and net income of -$177.4M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $130.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TDOCTeladoc Health, Inc.Follow TDOC — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.08 | 0.12 | 0.42 | 0.55 | 1.09 | 2.03 | 2.41 | 2.60 | 2.57 | 2.53 | 2.49 | |
| Gross profit | 0.06 | 0.09 | 0.29 | 0.37 | 0.70 | 1.38 | 1.66 | 1.84 | 1.82 | 1.76 | 1.72 | |
| Research & development | 0.01 | 0.02 | 0.05 | 0.06 | 0.16 | 0.31 | 0.33 | 0.35 | 0.31 | 0.28 | 0.27 | |
| Operating income | -0.06 | -0.06 | -0.07 | -0.08 | -0.51 | -0.27 | -13.65 | -0.25 | -1.02 | -0.26 | -0.19 | |
| Pre-tax income | -0.06 | -0.07 | -0.10 | -0.11 | -0.58 | -0.38 | -13.66 | -0.22 | -0.99 | -0.24 | -0.18 | |
| Income tax | 0.00 | 0.00 | 0.00 | -0.01 | -0.09 | 0.04 | -0.00 | 0.00 | 0.01 | -0.04 | -0.01 | |
| Net income | -0.06 | -0.07 | -0.10 | -0.10 | -0.49 | -0.43 | -13.66 | -0.22 | -1.00 | -0.20 | -0.18 | |
| Diluted EPS ($) | -2.91 | -1.75 | -1.47 | -1.38 | -5.36 | -2.73 | -84.60 | -1.34 | -5.87 | -1.14 | -0.99 | |
| Diluted shares (bn) | — | — | — | — | — | 0.157 | 0.161 | 0.165 | 0.171 | 0.176 | — |
USD billions · SEC XBRL
Teladoc Health, Inc. — questions
- What is Teladoc Health, Inc.'s revenue?
- $2.5B over the twelve months to 2026-06-30, down 2.1% year on year, from its 10-Q and 10-K filings.
- What is Teladoc Health, Inc.'s net income?
- -$177.4M over the twelve months to 2026-06-30.
- What is Teladoc Health, Inc.'s free cash flow?
- $130.8M over the twelve months to 2026-06-30.
- What are Teladoc Health, Inc.'s diluted earnings per share?
- $-0.99 over the twelve months to 2026-06-30.
Every figure on this page comes from Teladoc Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.